NCT05540912View on ClinicalTrials.gov

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

November 15, 2022

Study Completion Date

December 5, 2022

Conditions
Hypertension
Interventions
DRUG

D064+D701

Reference

DRUG

CKD-828 Formulation 1

Test 1

DRUG

CKD-828 Formulation 2

Test 2

Trial Locations (1)

Unknown

Central Hospital, Ansan-si

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY